Literature DB >> 7938174

Age, environmental factors and drug metabolism.

M S O'Mahony1, K W Woodhouse.   

Abstract

Both ageing and the environment have a significant impact on xenobiotic metabolism. Furthermore, there is some evidence from in vivo studies that the elderly respond to environmental changes to a lesser degree than younger individuals. This article reviews the available evidence and concentrates on possible underlying mechanisms.

Mesh：

Substances：

Year:  1994        PMID： 7938174     DOI： 10.1016/0163-7258(94)90066-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


  11 in total

Review 1.  Drug metabolism and ageing.

Authors:  M T Kinirons; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

Review 2.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics of goserelin.

Authors:  I D Cockshott
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 4.  Chronic obstructive pulmonary disease in the elderly: an update on pharmacological management.

Authors:  Amy L Dzierba; Sanja Jelic
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 7.  Adverse drug reactions in elderly patients.

Authors:  P A Routledge; M S O'Mahony; K W Woodhouse
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

8.  Intraocular pressure in genetically distinct mice: an update and strain survey.

Authors:  O V Savinova; F Sugiyama; J E Martin; S I Tomarev; B J Paigen; R S Smith; S W John
Journal:  BMC Genet       Date:  2001-08-09       Impact factor: 2.797

9.  The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction.

Authors:  Naser Aslanabadi; Naser Safaie; Fereshteh Talebi; Samaneh Dousti; Taher Entezari-Maleki
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

10.  The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population.

Authors:  Naser Aslanabadi; Naser Safaie; Faezeh Shadfar; Mohammad Reza Taban-Sadeghi; Hossein Feizpour; Simin Ozar Mashayekhi; Hadi Hamishehkar; Naser Khezerlou Aghdam; Samaneh Dousti; Hossein Namdar; Taher Entezari-Maleki
Journal:  J Res Pharm Pract       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.